Chemours Co (CC) director reports 2,226 deferred stock units in Form 4

Rhea-AI Filing Summary

Chemours Company director reports deferred stock units grant

A director of Chemours Company reported receiving 2,226 deferred stock units on 12/31/2025. Each deferred stock unit is the economic equivalent of one share of Chemours common stock and becomes payable in the first month after the director’s termination of service. The transaction price is listed as $11.79 per unit. Following this grant, the reporting person beneficially owns a total of 6,216.3946 deferred stock units, which include both deferred stock units and related dividend equivalent units, all held in direct ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MATHER COURTNEY

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DE 19801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	12/31/2025		A		2,226		(1)	(1)	Common Stock	2,226	$11.79	6,216.3946(2)	D

Explanation of Responses:

1. Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the first month following the Reportring Person's terminatrion of service as a director.

2. Includes deferred stock units and dividend equivalent units.

	/s/ Eric Stein, Attorney-in-Fact	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Chemours Co (CC) disclose in this Form 4?

Chemours disclosed that one of its directors received 2,226 deferred stock units on 12/31/2025, as reported in Table II of the filing.

What are the deferred stock units reported for Chemours Co (CC)?

The filing states that each deferred stock unit is the economic equivalent of one share of Chemours common stock and becomes payable in the first month following the director’s termination of service.

At what price were the Chemours (CC) deferred stock units recorded?

The transaction lists a price of $11.79 per deferred stock unit in connection with the 2,226 units acquired on 12/31/2025.

How many Chemours (CC) deferred stock units does the director own after this transaction?

After the reported transaction, the director beneficially owns 6,216.3946 deferred stock units, held in direct ownership, including deferred stock units and dividend equivalent units.

When will the Chemours (CC) deferred stock units be paid out to the director?

The filing explains that the deferred stock units become payable in the first month following the reporting person’s termination of service as a director.

Does the Chemours (CC) Form 4 include dividend equivalent units?

Yes. The footnotes indicate that the reported holdings include deferred stock units and dividend equivalent units as part of the total beneficial ownership.